Cargando…

Author's Response to Letters to the Editor regarding “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”

Detalles Bibliográficos
Autor principal:	Park, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Occupational Safety and Health Research Institute 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346998/ https://www.ncbi.nlm.nih.gov/pubmed/35936197 http://dx.doi.org/10.1016/j.shaw.2022.01.002

Ejemplares similares

Letter to the Editor Regarding “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”
por: Osman-Sypher, Sahar
Publicado: (2022)

Letter to the Editor Concerning “Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies”
por: Chappelle, Anne H.
Publicado: (2022)

Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies
por: PARK, Robert M.
Publicado: (2021)

Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease.
por: Peters, J M, et al.
Publicado: (1975)

Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry
por: Collins, James J., et al.
Publicado: (2017)

Response from Authors to the Letter to the Editor
por: Appendino, Juan Pablo, et al.
Publicado: (2021)

Respiratory effects in toluene diisocyanate manufacture: a multidisciplinary approach.
por: Weill, H, et al.
Publicado: (1975)

Neurogenic Inflammation: Literature on Toluene Diisocyanate
por: Mapp, Cristina
Publicado: (1994)

Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
por: Horn, Evelyn, et al.
Publicado: (2020)

Authors' Response to Letter to the Editor. Fake Union
por: Oba, Hiroki, et al.
Publicado: (2023)

Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Annovazzi, Pietro, et al.
Publicado: (2018)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Response from the authors to the letter to editor (MVR in infants)
por: Dave, Hitendu
Publicado: (2021)

Antibodies to toluene diisocyanate in an environmentally exposed population.
por: Orloff, K G, et al.
Publicado: (1998)

Author Response to Letter to the Editor
por: Ha, Jongmok, et al.
Publicado: (2019)

Author Response to Letter to the Editor
por: Castrillo-Fraile, Victoria, et al.
Publicado: (2020)

Authors’ response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations
por: D'Amato, Gennaro, et al.
Publicado: (2021)

Response from Authors to Letter to Editor ‘In Search of Unity in Diversity’
por: Selvan, Chitra, et al.
Publicado: (2022)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis
por: Stella, Salvatore Massimo, et al.
Publicado: (2022)

Letter to the Editor regarding Meta-analysis of the efficacy of gabapentin: a response
por: Masoud, Ahmed Taher, et al.
Publicado: (2022)

Letter to the Editor Response
por: Matava, Matthew, et al.
Publicado: (2013)

Letter to the Editor: Authors' Response
por: Cetin, Mehtap Bilgin, et al.
Publicado: (2022)

Role of clusterin/progranulin in toluene diisocyanate-induced occupational asthma
por: Choi, Gil-Soon, et al.
Publicado: (2018)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Response to the Letter to the Editor Regarding “Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials”
por: Suez, Daniel, et al.
Publicado: (2017)

A Letter to the Editor on the Article by Farnam et al.−Author's Response
por: Farnaz, Farnam, et al.
Publicado: (2015)

Authors’ Response to Drs. Ece Salihoglu and Ziya Salihoglu’s Letter to the Editor
por: Morton, Sophie E., et al.
Publicado: (2019)

Author reply to letter to editor “melatonin as fetal neuroprotection: Links and risks”
por: Lien, Reyin
Publicado: (2020)

Response-letter to the editor regarding nutrient density of beverages in relation to climate impact
por: Smedman, Annika, et al.
Publicado: (2010)

Response to letter to editor regarding Variability of symmetric dimethylarginine in apparently healthy dogs
por: Kopke, Matthew A., et al.
Publicado: (2018)

Response to letter to editor regarding Seizure‐precipitating factors in dogs with idiopathic epilepsy
por: Forsgård, Johanna, et al.
Publicado: (2019)

Response to letter to editor regarding ECEIM consensus statement on equine metabolic syndrome
por: Durham, Andy E., et al.
Publicado: (2019)

Letters to the Editor / Author’s reply
por: Ozdemir, Mikail, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qj3n4fm1dmtnli4ckja2aqndm